stockportfolio.pro
DHR vs TMO: Which Stock Is the Better Buy?
Danaher Corporation and Thermo Fisher Scientific Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — DHR vs TMO, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Danaher Corporation (DHR) | Thermo Fisher Scientific Inc. (TMO) | |
|---|---|---|
| Market cap | $140.1B | $194.5B |
| Revenue (latest FY) | $24.57B | $44.56B |
| Net income (latest FY) | $3.61B | $6.70B |
| Revenue growth (5y CAGR) | 2.0% | 6.7% |
| Net margin | 14.7% | 15.0% |
| Return on equity | 6.9% | 12.6% |
| P/E ratio | 38.3 | 28.7 |
| Dividend yield | 0.8% | 0.4% |
| Profitable years (of last 10) | 10 | 7 |
| Positive free cash flow | Yes | Yes |
See the full DHR vs TMO breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open DHR's full financials → Open TMO's full financials →More comparisons
Frequently asked questions
Which is bigger, DHR or TMO?
Thermo Fisher Scientific Inc. is larger by market capitalization — $194.5B versus $140.1B.
Which grows faster, DHR or TMO?
Over the last five fiscal years, Thermo Fisher Scientific Inc. grew revenue faster — 6.7%/yr versus 2.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.